The Human Microbiome Project: Beginning and Future Status
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In 1884 Robert Koch and Friedrich Loeffler published Koch’s Postulates defining our historical understanding of the relationship between an organism and infection: one organism: one disease. In the last decade with research on the microbial community living on and in humans, a new concept of microbial diseases has emerged; that is, alterations of the microbial community can lead to disease including an extension beyond traditional “infectious” diseases to include metabolic disorders such as type 2 diabetes and obesity. As we continue to gain knowledge about the functions of the normal microbiome and the effects of alterations of the microbial population on disease pathogenesis, a new era of diagnostics and therapeutics will evolve.
Abstract
In 1884 Robert Koch and Friedrich Loeffler published Koch’s Postulates defining our historical understanding of the relationship between an organism and infection: one organism: one disease. In the last decade with research on the microbial community living on and in humans, a new concept of microbial diseases has emerged; that is, alterations of the microbial community can lead to disease including an extension beyond traditional “infectious” diseases to include metabolic disorders such as type 2 diabetes and obesity. As we continue to gain knowledge about the functions of the normal microbiome and the effects of alterations of the microbial population on disease pathogenesis, a new era of diagnostics and therapeutics will evolve.
참고문헌 (26)
- Human Microbiome Project Consortium, "A framework for human microbiome research", Nature, 486, pp.215~221 (2012)
- Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
- NIH HMP Working Group, "The NIH Human Microbiome Project", Genome Res, 19, pp.2317~2323 (2009)
- Lander ES, "Initial sequencing and analysis of the human genome", Nature, 409, pp.860~921 (2001)
- Venter JC, "The sequence of the human genome", Science, 291, pp.1304~1351 (2001)
- Lander ES, "Initial impact of the sequencing of the human genome", Nature, 470, pp.187~197 (2011)
- Relman DA, "Microbiology: Learning about who we are", Nature, 486, pp.194~195 (2012)
- Parfrey LW, "Spatial and temporal variability of the human microbiota", Clin Microbiol Infect, 18(Suppl 4), pp.8~11 (2012)
- Gevers D, "The Human Microbiome Project: a community resource for the healthy human microbiome", PLoS Biol, 10, pp.e1001377~ (2012)
- Huse SM, "A core human microbiome as viewed through 16S rRNA sequence clusters", PLoS One, 7, pp.e34242~ (2012)
- Cho I, "The human microbiome: at the interface of health and disease", Nat Rev Genet, 13, pp.260~270 (2012)
- Grice EA, "The skin microbiome", Nat Rev Microbiol, 9, pp.244~253 (2011)
- Morgan XC, "Biodiversity and functional genomics in the human microbiome", Trends Genet, 29, pp.51~58 (2013)
- Fettweis JM, "A new era of the vaginal microbiome: advances using next-generation sequencing", Chem Biodivers, 9, pp.965~976 (2012)
- Srinivasan S, "Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria", PLoS One, 7, pp.e37818~ (2012)
- Li E, "Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition", PLoS One, 7, pp.e26284~ (2012)
- Petrof EO, "Microbial ecosystems therapeutics: a new paradigm in medicine?", Benef Microbes, 4, pp.53~65 (2013)
- Petrof EO, "Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut", Microbiome, 1, pp.3~ (2013)
- Allen-Vercoe E, "A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics", Can J Gastroenterol, 26, pp.457~462 (2012)
- Damman CJ, "The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?", Am J Gastroenterol, 107, pp.1452~1459 (2012)
- Vincent C, "Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection", Microbiome, 1, pp.18~ (2013)
- Morrow AL, "Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants", Microbiome, 1, pp.13~ (2013)
- Berry D, "Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?", Best Pract Res Clin Gastroenterol, 27, pp.47~58 (2013)
- Elinav E, "NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis", Cell, 145, pp.745~757 (2011)
- Wu S, "A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses", Nat Med, 15, pp.1016~1022 (2009)
- Hajishengallis G, "The keystone-pathogen hypothesis", Nat Rev Microbiol, 10, pp.717~725 (2012)